Covered recipient · General Payments record
ANNA MARIE HUSMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,267.39
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $285.98 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Grifols USA, LLC | $57.04 | 3 |
| Radius Health, Inc. | $47.53 | 3 |
| Daiichi Sankyo Inc. | $44.37 | 2 |
| Novo Nordisk AS | $29.66 | 2 |
| Amgen Inc. | $21.72 | 1 |
| Actelion Pharmaceuticals US, Inc. | $20.32 | 1 |
| ABBVIE INC. | $19.65 | 1 |
| Dynavax Technologies Corporation | $16.28 | 1 |
| PFIZER INC. | $14.72 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.65 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376538 | CMS |
| Actelion Pharmaceuticals US, Inc. | $20.32 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078912541 | CMS |
| Amgen Inc. | $21.72 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115744359 | CMS |
| Daiichi Sankyo Inc. | $26.42 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089435808 | CMS |
| Daiichi Sankyo Inc. | $17.95 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089435810 | CMS |
| Dynavax Technologies Corporation | $16.28 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082149817 | CMS |
| Grifols USA, LLC | $16.14 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124726696 | CMS |
| Grifols USA, LLC | $18.70 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124726698 | CMS |
| Grifols USA, LLC | $22.20 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124726694 | CMS |
| Novo Nordisk Inc | $15.38 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100287644 | CMS |
| Novo Nordisk Inc | $14.28 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100598367 | CMS |
| PFIZER INC. | $14.72 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131689593 | CMS |
| Radius Health, Inc. | $14.62 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090007136 | CMS |
| Radius Health, Inc. | $13.61 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090007142 | CMS |
| Radius Health, Inc. | $19.30 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090007146 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.69 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137767061 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.